In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Island Pharmaceuticals Limited Balance Sheet Statement - Assets

As of 30 Jun 2024, The total current assets of Island Pharmaceuticals Limited (ASX:ILA) was around $2,564,471 which consisted of $1,660,377 of Cash, no Inventory and $890,667 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$1,660,377
Current assets
$2,564,471
Total assets
$2,564,471

The latest balance sheet of Island Pharmaceuticals Limited also showed no Property Plant Equipment and no Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $2,564,471.

Island Pharmaceuticals Limited Balance Sheet Statement - Liabilities

ILA's latest annual results shows the balance sheet has $311,807 of Accounts Payable. Also there were $421,968 of Short/Long term debt, no Long term debt, no Other Current liabilities and $1,045,624 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$311,807
Current liabilities
$1,045,624
Total liabilities
$1,045,624

As per the 30 Jun 2024's annual report of Island Pharmaceuticals Limited, the total liabilities were $1,045,624.

ILA Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Island Pharmaceuticals Limited showed the total stock holder equity was $1,518,847 which consisted of $22,393,812 of Common stocks, $-21,200,056 of Retained earnings and no Other stock holder equity.

ILA Balance Sheet Statement History

Following table shows the history of balance sheet for Island Pharmaceuticals Limited (ILA).

30 Jun 2024 30 Jun 2023 30 Jun 2022 30 Jun 2021
Cash 1,660,377 1,998,263 4,787,437 6,460,644
Net Receivables 890,667 17,231 20,890 59,147
Inventory - - - -
Total Current Assets 2,564,471 2,049,219 4,898,876 6,635,910
Property Plant Equipment - - - -
Good Will - - - -
Intangible Assets - - - -
Other Assets - - - -
Deferred Long Term Asset Charges - - - -
Total Assets 2,564,471 2,049,219 4,898,876 6,635,910
Accounts Payable 311,807 112,503 240,885 81,957
Short/Long Term Debt 421,968 - - -
Other Current Liabilities - - - -
Long Term Debt - - - -
Other Liabilities - - - -
Total Current Liabilities 1,045,624 263,846 580,733 236,830
Total Liabilities 1,045,624 263,846 580,733 236,830
Common Stock 22,393,812 19,900,792 19,900,792 19,825,792
Retained Earnings -21,200,056 -19,763,257 -4,734,299 -2,127,414
Treasury Stock - - - -
Other Stockholder Equity - - - -
Total Stockholder Equity 1,518,847 1,785,373 4,318,143 6,399,080
Net Tangible Assets 1,518,847 1,785,373 4,318,143 6,399,080

Island Pharmaceuticals Limited (ASX:ILA) Balance Sheet Statement FAQ

1. How much Cash Island Pharmaceuticals Limited has on their balance sheet?

As of 30 Jun 2024, Island Pharmaceuticals Limited (ASX:ILA) has $1,660,377 of Cash.

2. What's the long term debt of Island Pharmaceuticals Limited?

As per the latest Balance sheet of Island Pharmaceuticals Limited (ASX:ILA), it has no Long term debt.

3. How much share holder equity does Island Pharmaceuticals Limited has?

The Island Pharmaceuticals Limited (ASX:ILA)'s balance sheet shows that it has $1,518,847 of Total stock holder equity.